LIVER CANCER 润色咨询

Liver Cancer

出版年份:暂无数据 年文章数:205 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=973107, encodeId=9faf9e3107ad, content=再次第9天被拒。建议转投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Jun 12 18:05:20 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917870, encodeId=17d691e87051, content=审稿速度:1.0<br>偏重的研究方向:肝癌<br>经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db085120923, createdName=1463624cm61暂无昵称, createdTime=Mon Jan 18 21:37:56 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578037, encodeId=83845e8037d8, content=有没有今年发的? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1daa5131984, createdName=ybcfj, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560104, encodeId=bef85601046f, content=v为什么?感觉杂志的文章都还好吧<span class="quote">princesun083 2018-06-27 00:00:00 发表:<br>被镇压了</span>, beContent=princesun083 2018-06-27 00:00:00 发表: 被镇压了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558524, encodeId=48d955852442, content=被镇压了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2021-06-12 1dd96cb3m86(暂无匿称)

    再次第9天被拒。建议转投。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=973107, encodeId=9faf9e3107ad, content=再次第9天被拒。建议转投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Jun 12 18:05:20 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917870, encodeId=17d691e87051, content=审稿速度:1.0<br>偏重的研究方向:肝癌<br>经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db085120923, createdName=1463624cm61暂无昵称, createdTime=Mon Jan 18 21:37:56 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578037, encodeId=83845e8037d8, content=有没有今年发的? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1daa5131984, createdName=ybcfj, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560104, encodeId=bef85601046f, content=v为什么?感觉杂志的文章都还好吧<span class="quote">princesun083 2018-06-27 00:00:00 发表:<br>被镇压了</span>, beContent=princesun083 2018-06-27 00:00:00 发表: 被镇压了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558524, encodeId=48d955852442, content=被镇压了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2021-01-18 1463624cm61暂无昵称

    审稿速度:1.0
    偏重的研究方向:肝癌
    经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=973107, encodeId=9faf9e3107ad, content=再次第9天被拒。建议转投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Jun 12 18:05:20 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917870, encodeId=17d691e87051, content=审稿速度:1.0<br>偏重的研究方向:肝癌<br>经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db085120923, createdName=1463624cm61暂无昵称, createdTime=Mon Jan 18 21:37:56 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578037, encodeId=83845e8037d8, content=有没有今年发的? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1daa5131984, createdName=ybcfj, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560104, encodeId=bef85601046f, content=v为什么?感觉杂志的文章都还好吧<span class="quote">princesun083 2018-06-27 00:00:00 发表:<br>被镇压了</span>, beContent=princesun083 2018-06-27 00:00:00 发表: 被镇压了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558524, encodeId=48d955852442, content=被镇压了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2019-10-17 ybcfj

    有没有今年发的?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=973107, encodeId=9faf9e3107ad, content=再次第9天被拒。建议转投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Jun 12 18:05:20 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917870, encodeId=17d691e87051, content=审稿速度:1.0<br>偏重的研究方向:肝癌<br>经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db085120923, createdName=1463624cm61暂无昵称, createdTime=Mon Jan 18 21:37:56 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578037, encodeId=83845e8037d8, content=有没有今年发的? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1daa5131984, createdName=ybcfj, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560104, encodeId=bef85601046f, content=v为什么?感觉杂志的文章都还好吧<span class="quote">princesun083 2018-06-27 00:00:00 发表:<br>被镇压了</span>, beContent=princesun083 2018-06-27 00:00:00 发表: 被镇压了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558524, encodeId=48d955852442, content=被镇压了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-08-15 1dd96cb3m86(暂无匿称)

    v为什么?感觉杂志的文章都还好吧princesun083 2018-06-27 00:00:00 发表:
    被镇压了

    princesun083 2018-06-27 00:00:00 发表: 被镇压了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=973107, encodeId=9faf9e3107ad, content=再次第9天被拒。建议转投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Jun 12 18:05:20 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917870, encodeId=17d691e87051, content=审稿速度:1.0<br>偏重的研究方向:肝癌<br>经验分享:投稿3天后直接被拒,投稿后status处一直是空白的,3天后直接显示decision: reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db085120923, createdName=1463624cm61暂无昵称, createdTime=Mon Jan 18 21:37:56 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578037, encodeId=83845e8037d8, content=有没有今年发的? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1daa5131984, createdName=ybcfj, createdTime=Thu Oct 17 00:00:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560104, encodeId=bef85601046f, content=v为什么?感觉杂志的文章都还好吧<span class="quote">princesun083 2018-06-27 00:00:00 发表:<br>被镇压了</span>, beContent=princesun083 2018-06-27 00:00:00 发表: 被镇压了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558524, encodeId=48d955852442, content=被镇压了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 princesun083

    被镇压了

    0

共29条页码: 2/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分